Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic targets for cardiac fibrosis: from old school to next-gen
Joshua G. Travers, Charles A. Tharp, Marcello Rubino, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 5
Open Access | Times Cited: 109

Showing 1-25 of 109 citing articles:

Calycosin reduces myocardial fibrosis and improves cardiac function in post-myocardial infarction mice by suppressing TGFBR1 signaling pathways
Guang‐Hong Chen, Honglin Xu, Tong Xu, et al.
Phytomedicine (2022) Vol. 104, pp. 154277-154277
Closed Access | Times Cited: 52
Emerging epigenetic therapies of cardiac fibrosis and remodelling in heart failure: from basic mechanisms to early clinical development
Timothy A. McKinsey, Roger Foo, Chukwuemeka George Anene-Nzelu, et al.
Cardiovascular Research (2022) Vol. 118, Iss. 18, pp. 3482-3498
Open Access | Times Cited: 40
Cardiac Fibrosis in heart failure: Focus on non-invasive diagnosis and emerging therapeutic strategies
Susana Ravassa, Begoña López, Thomas A. Treibel, et al.
Molecular Aspects of Medicine (2023) Vol. 93, pp. 101194-101194
Open Access | Times Cited: 38
Multiscale drug screening for cardiac fibrosis identifies MD2 as a therapeutic target
Hao Zhang, Phung N. Thai, Rabindra V. Shivnaraine, et al.
Cell (2024)
Closed Access | Times Cited: 11
Macrophage and fibroblast trajectory inference and crosstalk analysis during myocardial infarction using integrated single-cell transcriptomic datasets
Da Ke, Mingzhen Cao, Jian Ni, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 10
Role and molecular mechanisms of SGLT2 inhibitors in pathological cardiac remodeling (Review)
B K Chen, Jing Guo, Ye Hongmei, et al.
Molecular Medicine Reports (2024) Vol. 29, Iss. 5
Open Access | Times Cited: 9
Nitro-oleic acid alleviates inflammation and fibrosis by regulating macrophage polarization and fibroblast activation to improve cardiac function in MI mice
Zhen Ma, Bingxin Huang, Chenjun Yin, et al.
International Immunopharmacology (2025) Vol. 146, pp. 113710-113710
Open Access | Times Cited: 1
Fibrosis: cross-organ biology and pathways to development of innovative drugs
Florian Rieder, Laura E. Nagy, Toby M. Maher, et al.
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 1
Evolving Myocardial Injury in Chronic Kidney Disease Assessed by Multiparameter Magnetic Resonance in a Rabbit Model
Shiqi Jin, Fan Wang, Huaibi Huo, et al.
Journal of Magnetic Resonance Imaging (2025)
Closed Access | Times Cited: 1
Treatment of cardiac fibrosis: from neuro-hormonal inhibitors to CAR-T cell therapy
Paolo Morfino, Alberto Aimo, Vincenzo Castiglione, et al.
Heart Failure Reviews (2022)
Open Access | Times Cited: 35
Cardiac splicing as a diagnostic and therapeutic target
Michael Gotthardt, Victor Badillo Lisakowski, Victoria N. Parikh, et al.
Nature Reviews Cardiology (2023) Vol. 20, Iss. 8, pp. 517-530
Closed Access | Times Cited: 18
Myocardial fibrosis from the perspective of the extracellular matrix: mechanisms to clinical impact
Ida G. Lunde, Karoline Bjarnesdatter Rypdal, Sophie Van Linthout, et al.
Matrix Biology (2024) Vol. 134, pp. 1-22
Closed Access | Times Cited: 7
Advances in the study of S100A9 in cardiovascular diseases
Fengling Chen, Ziyu He, Chengming Wang, et al.
Cell Proliferation (2024) Vol. 57, Iss. 8
Open Access | Times Cited: 6
CAR-Macrophage Therapy Alleviates Myocardial Ischemia-Reperfusion Injury
Jiawan Wang, Heng Du, Wanrun Xie, et al.
Circulation Research (2024) Vol. 135, Iss. 12, pp. 1161-1174
Closed Access | Times Cited: 6
NADPH Oxidases in Diastolic Dysfunction and Heart Failure with Preserved Ejection Fraction
James P. Teuber, Kobina Essandoh, Scott L. Hummel, et al.
Antioxidants (2022) Vol. 11, Iss. 9, pp. 1822-1822
Open Access | Times Cited: 27
Review: Acetylation mechanisms and targeted therapies in cardiac fibrosis
Weikang Liu, Qiuhuan Yuan, Shengchuan Cao, et al.
Pharmacological Research (2023) Vol. 193, pp. 106815-106815
Open Access | Times Cited: 16
Intercellular mitochondrial component transfer triggers ischemic cardiac fibrosis
Chan Zhang, Hao Hao, Yishi Wang, et al.
Science Bulletin (2023) Vol. 68, Iss. 16, pp. 1784-1799
Closed Access | Times Cited: 16
Cardiovascular Protection with a Long-Acting GLP-1 Receptor Agonist Liraglutide: An Experimental Update
Collin Vandemark, Jimmy Nguyen, Zhi‐Qing Zhao
Molecules (2023) Vol. 28, Iss. 3, pp. 1369-1369
Open Access | Times Cited: 15
Assessment of the Cardiac Noncoding Transcriptome by Single-Cell RNA Sequencing Identifies FIXER , a Conserved Profibrogenic Long Noncoding RNA
Parisa Aghagolzadeh, Isabelle Plaisance, Riccardo Bernasconi, et al.
Circulation (2023) Vol. 148, Iss. 9, pp. 778-797
Open Access | Times Cited: 15
Combining three independent pathological stressors induces a heart failure with preserved ejection fraction phenotype
Yijia Li, Hajime Kubo, Daohai Yu, et al.
AJP Heart and Circulatory Physiology (2023) Vol. 324, Iss. 4, pp. H443-H460
Open Access | Times Cited: 14
Chromatin Remodeling Drives Immune-Fibroblast Crosstalk in Heart Failure Pathogenesis
Michael Alexanian, Arun Padmanabhan, Tomohiro Nishino, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 13
SGLT-2 inhibitors as novel treatments of multiple organ fibrosis
Jun-Pei Hu, Jianhui Teng, Shan Hui, et al.
Heliyon (2024) Vol. 10, Iss. 8, pp. e29486-e29486
Open Access | Times Cited: 5
Modulation of anti-cardiac fibrosis immune responses by changing M2 macrophages into M1 macrophages
Shiqi Chen, Kan Wang, Zhengfeng Fan, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 5
Microneedle system for tissue engineering and regenerative medicines: a smart and efficient therapeutic approach
Muhammad Umar Aslam Khan, Muhammad Azhar Aslam, Mohd Faizal Abdullah, et al.
Biofabrication (2024) Vol. 16, Iss. 4, pp. 042005-042005
Closed Access | Times Cited: 5
Loss of KDM5B ameliorates pathological cardiac fibrosis and dysfunction by epigenetically enhancing ATF3 expression
Bo Wang, Yong Tan, Yunkai Zhang, et al.
Experimental & Molecular Medicine (2022) Vol. 54, Iss. 12, pp. 2175-2187
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top